Komori
Japan Lifeline (7575) · FactFirst stated

Acquisition of Cross Vascular, Inc. and establishment as a US sub-subsidiary

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Acquisition of Cross Vascular to obtain its radiofrequency system for transseptal punctureA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「At a meeting of the Board of Directors held on 29 September 2026, the company resolved to acquire all shares of US-based Cross Vascular, Inc. through its wholly owned subsidiary JLL Med USA Inc. and make it a sub-subsidiary. On 1 October 2026, the company entered into a share transfer agreement and acquired all shares on the same date.」

    The company acquired 100% of US-based Cross Vascular, Inc., which develops high-frequency systems for transseptal puncture, through JLL Med USA Inc., making it a sub-subsidiary. The company disclosed the incorporation of the acquisition into its global portfolio and the acceleration of its US business expansion.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Japan Lifeline yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.